Why the study?
Does gemcitabine and docetaxel show activity as first-line treatment in patients with unresectable leiomyosarcoma?
Population
Patients with locally advanced/metastatic unresectable leiomyosarcoma in the first line setting
Authors
Loading...
May support first-line gemcitabine-docetaxel in unresectable leiomyosarcoma; leaves open randomized comparisons.
Does gemcitabine and docetaxel show activity as first-line treatment in patients with unresectable leiomyosarcoma?
Gemcitabine and docetaxel show activity as first-line chemotherapy for locally advanced or metastatic leiomyosarcoma, warranting further comparative trials.
Seddon et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: